🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: Immunotherapy drugs help the body to fight cancer. Scientists ...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2018-05-01
Trial ID
NCT03493945
Exploratory study on blood-borne biological markers and their correlation w...
Status
Completed
Location
Centre Georges François Leclerc
Start Date
2015-07
Trial ID
NCT02866149
Treatments Being Tested
This phase II trial tests the addition of chemotherapy, with carboplatin an...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2026-04-24
Trial ID
NCT07195734
Osimertinib is an epidermal growth factor receptor tyrosine kinase inhibito...
Status
Unknown
Location
CHU d'ANGERS
Start Date
2019-04-09
Trial ID
NCT03865511
Treatments Being Tested
This Phase Ib study is designed to evaluate the safety and pharmacokinetics...
Status
Terminated
Location
UC Davis Comprehensive Cancer Center
Start Date
2019-10-08
Trial ID
NCT03922477
Treatments Being Tested
This multi-site Phase II study will enroll adults with histologically confi...
Status
Recruiting
Location
Beijing Tiantan Hospital, Capital Medical University
Start Date
2026-01-15
Trial ID
NCT07297212
Treatments Being Tested
This pilot study is configured as a non-inferiority comparison of Performan...
Status
Recruiting
Location
Wake Forest Baptist Comprehensive Cancer Center
Start Date
2020-07-01
Trial ID
NCT04253964
Treatments Being Tested
This is an open label Phase 1, first-in-human (FIH) study of TST005, a bi-s...
Status
Terminated
Location
Gabrail Cancer Center
Start Date
2021-06-11
Trial ID
NCT04958434
Treatments Being Tested
Substudy 02C is part of a larger research study that is testing experimenta...
Status
Completed
Location
The Angeles Clinic and Research Institute ( Site 3009)
Start Date
2020-06-26
Trial ID
NCT04303169
Treatments Being Tested
1. Background and Rationale:: Galectin-3 (Gal-3) is a β-galactoside-bin...
Status
Recruiting
Location
Tel Aviv Sourasky Medical Center
Start Date
2025-12-03
Trial ID
NCT07485114
Treatments Being Tested